Organon & Co. Quarterly Income Tax Expense (Benefit) in USD from Q1 2020 to Q2 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Organon & Co. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2020 to Q2 2025.
- Organon & Co. Income Tax Expense (Benefit) for the quarter ending June 30, 2025 was $84M, a 110% increase year-over-year.
- Organon & Co. Income Tax Expense (Benefit) for the twelve months ending June 30, 2025 was -$34M, a 90.1% increase year-over-year.
- Organon & Co. annual Income Tax Expense (Benefit) for 2024 was -$57M, a 83.7% increase from 2023.
- Organon & Co. annual Income Tax Expense (Benefit) for 2023 was -$350M, a 271% decline from 2022.
- Organon & Co. annual Income Tax Expense (Benefit) for 2022 was $205M, a 15.2% increase from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)